Study Finds Bariatric Surgery Yields Fivefold Greater Weight Loss Than Ozempic

Recent research highlights bariatric surgery as significantly more effective for weight loss in obese patients compared to GLP-1 receptor agonist drugs like Ozempic and Mounjaro, with surgery patients losing an average of 58 pounds over two years versus about 12 pounds for those on medications. This disparity is partly attributed to high discontinuation rates of GLP-1 treatments due to side effects or unmet expectations. In contrast, Pilates-based fitness apps like Reverse Health offer a non-invasive, accessible option tailored for women over 40 to manage menopause-related weight gain and improve health through low-impact exercise routines. Additionally, Berberine, a plant-derived supplement dubbed 'Nature’s Ozempic,' shows modest weight loss effects in early studies but requires further human research. Meanwhile, moderate wine consumption, especially red wine rich in antioxidants like resveratrol, may positively influence bone mineral density, particularly in postmenopausal women, potentially reducing fracture risk. Together, these findings suggest a spectrum of weight management and health strategies, from surgical interventions to lifestyle and supplement approaches, each with varying efficacy and considerations.